Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2

被引:10
作者
Boulme, F [1 ]
PeralaHeape, M [1 ]
SarihCottin, L [1 ]
Litvak, S [1 ]
机构
[1] CNRS, IBGC, LAB REGER, F-33077 BORDEAUX, FRANCE
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1997年 / 1351卷 / 03期
基金
芬兰科学院;
关键词
HIV-1; HIV-2; replication; reverse transcription; inhibition; antisense; trans-activating region;
D O I
10.1016/S0167-4781(97)00026-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense oligonucleotides (ODNs) overlapping the stem-loop structure of the trans-activating responsive (TAR) element at the 5' end of HIV-1 and HIV-2 viral RNAs were tested for their inhibitory effect on cDNA synthesis by HIV-1 and HIV-2 reverse transcriptases (RT). Inhibition of reverse transcription is sequence-specific and enhanced by the presence of the RT-associated RNase H activity. The degree of inhibition obtained with the anti-TAR antisense is significantly higher than with other HIV-1 targeted antisense ODNs used before [1]. Gel retardation showed a stable specific complex between the 16- and 25-mer anti-TAR HIV-1 selected ODNs and the target region. No complex was observed with a non-inhibitor 22-mer anti-TAR ODN and with the corresponding control sequences. Targeting of the first stem-loop in the 5' region of HIV-2 RNA by anti-TAR ODNs inhibited very strongly reverse transcription by HIV-2 RT. The structure of the antisense and the target sequence affect annealing efficiency and hence the degree of inhibition of reverse transcription. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 35 条
[1]  
AGRAWAL S, 1992, PROSPECTS ANTISENSE, P143
[2]   GENETIC-VARIABILITY OF THE AIDS VIRUS - NUCLEOTIDE-SEQUENCE ANALYSIS OF 2 ISOLATES FROM AFRICAN PATIENTS [J].
ALIZON, M ;
WAINHOBSON, S ;
MONTAGNIER, L ;
SONIGO, P .
CELL, 1986, 46 (01) :63-74
[3]   TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) [J].
ARYA, SK ;
GUO, C ;
JOSEPHS, SF ;
WONGSTAAL, F .
SCIENCE, 1985, 229 (4708) :69-73
[4]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 LONG TERMINAL REPEAT - ANALYSIS OF REGULATORY ELEMENTS [J].
ARYA, SK ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) :9753-9757
[5]   EXPRESSION OF ACTIVE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE IN SACCHAROMYCES-CEREVISIAE [J].
BARR, PJ ;
POWER, MD ;
LEENG, CT ;
GIBSON, HL ;
LUCIW, PA .
BIO-TECHNOLOGY, 1987, 5 (05) :486-489
[6]   FUNCTIONAL SITES IN THE 5' REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FORM DEFINED STRUCTURAL DOMAINS [J].
BAUDIN, F ;
MARQUET, R ;
ISEL, C ;
DARLIX, JL ;
EHRESMANN, B ;
EHRESMANN, C .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (02) :382-397
[7]   SECONDARY STRUCTURE OF THE HIV-2 LEADER RNA COMPRISING THE TRANSFER RNA-PRIMER BINDING-SITE [J].
BERKHOUT, B ;
SCHONEVELD, I .
NUCLEIC ACIDS RESEARCH, 1993, 21 (05) :1171-1178
[8]   MECHANISMS OF THE INHIBITION OF REVERSE TRANSCRIPTION BY ANTISENSE OLIGONUCLEOTIDES [J].
BOIZIAU, C ;
THUONG, NT ;
TOULME, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :768-772
[9]   A PHOSPHOROTHIOATE OLIGONUCLEOTIDE BLOCKS REVERSE TRANSCRIPTION VIA AN ANTISENSE MECHANISM [J].
BOIZIAU, C ;
MOREAU, S ;
TOULME, JJ .
FEBS LETTERS, 1994, 340 (03) :236-240
[10]   SEQUENCE-SPECIFIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REVERSE TRANSCRIPTION BY ANTISENSE OLIGONUCLEOTIDES - COMPARATIVE-STUDY IN CELL-FREE ASSAYS AND IN HIV-INFECTED CELLS [J].
BORDIER, B ;
PERALAHEAPE, M ;
DEGOLS, G ;
LEBLEU, B ;
LITVAK, S ;
SARIHCOTTIN, L ;
HELENE, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9383-9387